Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 July 2024, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2024 to 11 July 2024
Minutes of the PRAC meeting 8-11 July 2024
Veterinary medicines European public assessment report (EPAR): Nobilis Multriva RT+IBm+ND+EDS, avian metapneumovirus, infectious bronchitis virus, Newcastle disease virus and eggdrop syndrome virus vaccine (inactivated), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Nobilis Multriva RT+IBm+ND+Gm+REOm, avian infectious bronchitis,avian reovirus,avian infectious bursal disease,Newcastle disease,Turkey rhinotracheitis virus, Status: Authorised
CTIS newsflash - 10 September 2024
Membership list: HMA-EMA joint Big Data Steering Group
Human medicines European public assessment report (EPAR): Nyxthracis (previously Obiltoxaximab SFL), obiltoxaximab, Date of authorisation: 18/11/2020, Revision: 3, Status: Withdrawn (authorisation)
Questions and answers - Info session on web-based electronic Application Form (eAF) add package
Member states contact points for translations review
Agenda of the CVMP meeting 10-12 September 2024